Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Romano Byaruhanga is active.

Publication


Featured researches published by Romano Byaruhanga.


Acta Obstetricia et Gynecologica Scandinavica | 2006

Audit of severe maternal morbidity in Uganda – implications for quality of obstetric care

Pius Okong; Josaphat Byamugisha; Florence Mirembe; Romano Byaruhanga; Staffan Bergström

Background. For every maternal death, there are probably 100 or more morbidities, but the quality of health care for these women who survive has rarely been an issue. The purpose of this study is to explore audit of severe obstetric morbidity and the concept of near miss in four referral hospitals in Uganda. Methods. This was an exploratory systematic enquiry into the care of a subset of women with severe morbidity designated as near miss cases by organ failure or dysfunction. Patient factors and environmental factors were also explored. Data were abstracted from clinical records and from interviews with patients, relatives, and health workers. Results. Records of 685 women with severe maternal morbidity were examined and 229 cases fulfilled the criteria for near miss cases. Obstetric hemorrhage, rupture of the uterus, puerperal sepsis, and abortion complications were the major conditions leading to the near miss state in more than three quarters of the patients. Nearly half the cases were at home when the events occurred. More than half the cases delayed to seek care, because the patients were unwilling, or relatives were not helpful. Similar proportion also experienced substandard care in the hospitals. Conclusions. A systemic analysis found substandard care and records, and patient‐related factors in more than half the cases of severe maternal morbidity. Audit of near miss cases might offer a non‐threatening stimulus for improving the quality of obstetric care.


Acta Paediatrica | 2005

The impact of newborn bathing on the prevalence of neonatal hypothermia in Uganda: A randomized, controlled trial

Anna Bergström; Romano Byaruhanga; Pius Okong

Aim: To elucidate the impact of bathing on the prevalence of hypothermia among newborn babies exposed to the skin‐to‐skin (STS) care technique before and after bathing. Methods: Non‐asphyxiated newborns after vaginal delivery (n=249) in a Ugandan referral hospital were consecutively enrolled and randomized either to bathing at 60 min postpartum (n=126) or no bathing (n=123). All mothers practised skin‐to‐skin care of their newborns. Four rectal and tympanic registrations of newborn temperatures were carried out in both groups directly after drying at birth, and at 60, 70 and 90 min postpartum. Results: Bathing of newborns in the first hour after delivery resulted in a significantly increased prevalence of hypothermia, defined as temperature <36.5°C, at 70 and at 90 min postpartum despite the use of warmed water and the application of the STS method. There was no neonatal mortality. Aside from the bathing procedure, no background factor potentially predisposing the newborns to hypothermia was identified.


AIDS | 2005

A randomized controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda.

Julie Bakobaki; Charles Lacey; Michael I. Bukenya; Andrew Nunn; Sheena McCormack; Romano Byaruhanga; Pius Okong; Stella Namukwaya; Heiner Grosskurth; Jimmy Whitworth

Objective:To assess the safety of dextrin sulphate (DS) gel compared to placebo gel in terms of local and systemic adverse events, and to determine the acceptability of dextrin sulphate gel. Design:A 4-week randomized trial of DS intra-vaginal gel, partially blinded, with placebo and observation control arms. Participants were randomized to use DS gel twice daily, placebo gel twice daily, DS gel pre-sex, or into an observation only arm. Methods:Sexually active women were recruited from post natal and HIV clinics at Nsambya Hospital, Kampala, Uganda. Screening, enrolment and follow-up visits took place every 1 or 2 weeks over an 8-week period and consisted of questionnaire interviews, colposcopy examinations, sexually transmitted infection screen and routine laboratory testing. Results:Out of a total of 172 women screened, 109 were randomized to use DS gel twice daily (65 women), placebo gel twice daily (15 women), DS gel pre-sex (nine women) or into an observation only arm (20 women). Two individuals had abnormal colposcopy findings in the DS twice daily gel use arm. Vaginal bleeding was reported as frequently by participants in the active gel arm as by participants in the placebo and observation only arms. No clinically significant difference was observed between arms in terms of vaginal flora, Candida, haemoglobin, white cell count, platelets, thrombin time, activated partial thromboplastin time, creatinine and aspartate aminotransferase results after 4 weeks of gel use. DS gel appeared to be acceptable to over 95% of the users. Conclusions:Results show a satisfactory safety and acceptability profile of dextrin sulphate gel.


Scandinavian Journal of Infectious Diseases | 2010

Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women.

Proscovia Namujju; Heljä-Marja Surcel; Reinhard Kirnbauer; Marjo Kaasila; Cecily Banura; Romano Byaruhanga; Moses Muwanga; Edward Mbidde; Pentti Koskela; Matti Lehtinen

Abstract Although infections with multiple human papillomavirus (HPV) types have been reported widely, more information is needed on the occurrence of the different types. We determined the distribution of seroprevalences to multiple HPV types in Finland and Uganda to compare the epidemiology of the different HPV types in the 2 populations. Serum samples were obtained from 2784 Finnish and 1964 Ugandan women (mean ages 22 y and 25 y, respectively) of whom 44% and 57%, respectively, had antibodies to at least 1 of the 7 HPV types (6, 11, 16, 18, 31, 33, 45) tested (p < 0.001). Multiple HPV antibody positivity was common. HPV45-seropositive Finns had a higher risk of having antibodies to other high-risk HPV types: HPV18 (odds ratio (OR) = 10.9), HPV31 (OR 6.1), HPV33 (OR 12.2), than their Ugandan counterparts: HPV18 (OR 3.4), HPV31 (OR 2.2), HPV33 (OR 3.3). Increased estimates for being double antibody-positive were also noted among HPV18- and HPV16-seropositive women, but there were no major differences between HPV16-seropositive Finns and Ugandans. In addition to biological and behavioural factors, iatrogenic and societal factors (screening vs no screening) may also result in the different occurrence of infections with the high-risk HPV types in Finland and Uganda.


Journal of Tropical Pediatrics | 2005

Neonatal Hypothermia in Uganda: Prevalence and Risk Factors

Romano Byaruhanga; Anna Bergström; Pius Okong


Midwifery | 2008

Perceptions among post-delivery mothers of skin-to-skin contact and newborn baby care in a periurban hospital in Uganda.

Romano Byaruhanga; Anna Bergström; Jude Tibemanya; Christine Nakitto; Pius Okong


Midwifery | 2011

Hurdles and opportunities for newborn care in rural Uganda

Romano Byaruhanga; Jesca Nsungwa-Sabiiti; Juliet Kiguli; Andrew Balyeku; Xavier Nsabagasani; Stefan Peterson


BMC Research Notes | 2011

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence

Proscovia B. Namujju; Lea Hedman; Klaus Hedman; Cecily Banura; Edward Mbidde; Dennison Kizito; Romano Byaruhanga; Moses Muwanga; Reinhard Kirnbauer; Heljä-Marja Surcel; Matti Lehtinen


Tropical Doctor | 2000

Improving healthcare by perinatal mortality audit and feedback.

Romano Byaruhanga


WOS | 2013

Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women

Proscovia B. Namujju; Heljae-Marja Surcel; Reinhard Kirnbauer; Marjo Kaasila; Cecily Banura; Romano Byaruhanga; Moses Muwanga; Edward Mbidde; Pentti Koskela; Matti Lehtinen

Collaboration


Dive into the Romano Byaruhanga's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Edward Mbidde

Uganda Virus Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Proscovia B. Namujju

Uganda Virus Research Institute

View shared research outputs
Top Co-Authors

Avatar

Stella Namukwaya

Uganda Virus Research Institute

View shared research outputs
Top Co-Authors

Avatar

Heljä-Marja Surcel

National Institute for Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

Marjo Kaasila

National Institute for Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

Pentti Koskela

National Institute for Health and Welfare

View shared research outputs
Researchain Logo
Decentralizing Knowledge